Evidence map›Paper›PMID 35518030›Full record

ArticleRSC advances2019

A proof of concept application of aptachain: ligand-induced self-assembly of a DNA aptamer.

Miguel A D Neves, Sladjana Slavkovic, Oren Reinstein, Aron A Shoara, Philip E Johnson

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Miguel A D NevesDepartment of Chemistry & Centre for Research on Biomolecular Interactions, York University 4700 Keele St. Toronto Ontario Canada M3J 1P3 pjohnson@yorku.ca nevesm@smh.ca.ORCID https://orcid.org/0000-0002-2220-486X
Sladjana SlavkovicDepartment of Chemistry & Centre for Research on Biomolecular Interactions, York University 4700 Keele St. Toronto Ontario Canada M3J 1P3 pjohnson@yorku.ca nevesm@smh.ca.
Oren ReinsteinDepartment of Chemistry & Centre for Research on Biomolecular Interactions, York University 4700 Keele St. Toronto Ontario Canada M3J 1P3 pjohnson@yorku.ca nevesm@smh.ca.
Aron A ShoaraDepartment of Chemistry & Centre for Research on Biomolecular Interactions, York University 4700 Keele St. Toronto Ontario Canada M3J 1P3 pjohnson@yorku.ca nevesm@smh.ca.ORCID https://orcid.org/0000-0002-5580-1273
Philip E JohnsonDepartment of Chemistry & Centre for Research on Biomolecular Interactions, York University 4700 Keele St. Toronto Ontario Canada M3J 1P3 pjohnson@yorku.ca nevesm@smh.ca.ORCID https://orcid.org/0000-0002-5573-4891
Toronto Public Health · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A challenge for the use of aptamers as biosensors is how to signal the occurrence of their ligand binding event into a signal that can be exploited in a detection scheme. Here, we present the concept of "aptachain" formation, where an aptamer is split into two overlapping or staggered strands and assembles into an extended oligomer upon ligand binding. This assembly of aptamers can then be used as a way to detect ligand binding by the aptamer. As an example of this concept, we employed the cocaine-binding aptamer as a model system, used its ability to tightly bind quinine and demonstrated its capability in a gold nanoparticle-based biosensing application. We used isothermal titration calorimetry to demonstrate that, when split into two overlapping DNA strands, the aptamer remains functional. Size-exclusion chromatography showed that the quinine-bound oligos form a larger assembly of aptamer units than in the absence of ligand. Finally, we used the oligomer forming ability of the aptachain oligos in a biosensor application for quinine that brings gold nanoparticles closer together resulting in a shift in their plasmonic resonance to a longer wavelength and an observed colour shift. We propose that splitting aptamers into overlapping strands that form oligomers in the presence of a ligand, aptachain formation, will be generally applicable to aptamers and prove useful in a variety of biotechnology applications.

Identifiers

PMID35518030
PMCPMC9059725
OpenAlexW2909747167

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.